Search research articles
Contact Us
Filters
Showing results (11-20 of 46) with videos related to
Page
of 5
Sort By:
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft
|
August 31, 2016
[Structural and morphological changes in the eyes of arterial hypertensive patients with and without anti-CCP-positive rheumatoid arthritis]
M Pahlitzsch, R Zielke, S Schlittgen, et al.
Scandinavian Journal of Rheumatology
|
June 27, 2015
Morning stiffness response with delayed-release prednisone after ineffective course of immediate-release prednisone
R Alten, R Holt, A Grahn, et al.
The Journal of Rheumatology
|
September 16, 2000
HLA-DRB1 genes, rheumatoid factor, and elevated C-reactive protein: independent risk factors of radiographic progression in early rheumatoid arthritis. Berlin Collaborating Rheumatological Study Group
J Listing, R Rau, B Müller, et al.
International Journal of Clinical Practice
|
December 21, 2004
Efficacy, safety and tolerability of lumiracoxib in patients with rheumatoid arthritis
P Geusens, R Alten, J Rovensky, et al.
Human Immunology
|
February 10, 1999
Differential surface expression of HLA-DRB1 and HLA-DRB4 among peripheral blood cells of DR4 positive individuals
G Czerwony, R Alten, E Gromnica-Ihle, et al.
Arthritis Care & Research
|
March 27, 2015
What Is the Relationship Between Morning Symptoms and Measures of Disease Activity in Patients With Rheumatoid Arthritis?
M Boers, F Buttgereit, K Saag, et al.
Annals of the Rheumatic Diseases
|
October 16, 2002
Atopic disorders in ankylosing spondylitis and rheumatoid arthritis
M Rudwaleit, B Andermann, R Alten, et al.
The Journal of Rheumatology
|
December 1, 1996
Diclofenac combined with cyclosporine in treatment refractory rheumatoid arthritis: longitudinal safety assessment and evidence of a pharmacokinetic/dynamic interaction
J M Kovarik, P Kurki, E Mueller, et al.
Annals of the Rheumatic Diseases
|
January 15, 2004
Inhibition of leukotriene B4-induced CD11B/CD18 (Mac-1) expression by BIIL 284, a new long acting LTB4 receptor antagonist, in patients with rheumatoid arthritis
R Alten, E Gromnica-Ihle, C Pohl, et al.
WHO Regional Publications. European Series
|
January 1, 1992
Pain: a kaleidoscope of ideas, concepts and approaches
M Zimmermann, R Alten, D Field, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 46) with videos related to
Sort By:
Page
of 5
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft
|
August 31, 2016
[Structural and morphological changes in the eyes of arterial hypertensive patients with and without anti-CCP-positive rheumatoid arthritis]
M Pahlitzsch, R Zielke, S Schlittgen, et al.
Scandinavian Journal of Rheumatology
|
June 27, 2015
Morning stiffness response with delayed-release prednisone after ineffective course of immediate-release prednisone
R Alten, R Holt, A Grahn, et al.
The Journal of Rheumatology
|
September 16, 2000
HLA-DRB1 genes, rheumatoid factor, and elevated C-reactive protein: independent risk factors of radiographic progression in early rheumatoid arthritis. Berlin Collaborating Rheumatological Study Group
J Listing, R Rau, B Müller, et al.
International Journal of Clinical Practice
|
December 21, 2004
Efficacy, safety and tolerability of lumiracoxib in patients with rheumatoid arthritis
P Geusens, R Alten, J Rovensky, et al.
Human Immunology
|
February 10, 1999
Differential surface expression of HLA-DRB1 and HLA-DRB4 among peripheral blood cells of DR4 positive individuals
G Czerwony, R Alten, E Gromnica-Ihle, et al.
Arthritis Care & Research
|
March 27, 2015
What Is the Relationship Between Morning Symptoms and Measures of Disease Activity in Patients With Rheumatoid Arthritis?
M Boers, F Buttgereit, K Saag, et al.
Annals of the Rheumatic Diseases
|
October 16, 2002
Atopic disorders in ankylosing spondylitis and rheumatoid arthritis
M Rudwaleit, B Andermann, R Alten, et al.
The Journal of Rheumatology
|
December 1, 1996
Diclofenac combined with cyclosporine in treatment refractory rheumatoid arthritis: longitudinal safety assessment and evidence of a pharmacokinetic/dynamic interaction
J M Kovarik, P Kurki, E Mueller, et al.
Annals of the Rheumatic Diseases
|
January 15, 2004
Inhibition of leukotriene B4-induced CD11B/CD18 (Mac-1) expression by BIIL 284, a new long acting LTB4 receptor antagonist, in patients with rheumatoid arthritis
R Alten, E Gromnica-Ihle, C Pohl, et al.
WHO Regional Publications. European Series
|
January 1, 1992
Pain: a kaleidoscope of ideas, concepts and approaches
M Zimmermann, R Alten, D Field, et al.
Page
of 5